{
    "clinical_study": {
        "@rank": "68668", 
        "arm_group": {
            "arm_group_label": "MSC", 
            "arm_group_type": "Experimental", 
            "description": "infusion of MSCs at day 0, 7, 14, 21"
        }, 
        "brief_summary": {
            "textblock": "Central nervous system (CNS) injury leads to morbidity in patients, which has few good\n      rehabilitation measures. Mesenchymal stem cells seem to have regenerative and\n      tissue-repairing capabilities. The investigators design this study to infuse mesenchymal\n      stem cells (MSCs) intrathecally to CNS injury patients, and observe the safety and efficacy\n      by recording the change of nervous system scores, trying to prove the effect of MSC in\n      rehabilitate CNS injury."
        }, 
        "brief_title": "Mesenchymal Stem Cells in Central Nervous System Injury", 
        "completion_date": {
            "#text": "January 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Central Nervous System Injury", 
        "condition_browse": {
            "mesh_term": [
                "Trauma, Nervous System", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  CNS injury > 3 months\n\n          -  age > 18 years\n\n          -  willing to give consent\n\n        Exclusion Criteria:\n\n          -  any contradiction to intrathecal infusion\n\n          -  age < 18 years\n\n          -  CNS injury < 3 months\n\n          -  CNS injury > 3 years"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01719640", 
            "org_study_id": "MSC-CNS"
        }, 
        "intervention": {
            "arm_group_label": "MSC", 
            "intervention_name": "infusion of MSCs", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "mesenchymal stem cell", 
            "central nervous system"
        ], 
        "lastchanged_date": "October 30, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Fuzhou", 
                    "country": "China", 
                    "state": "Fujian", 
                    "zip": "350025"
                }, 
                "name": "Fuzhou General Hospital, Xiamen Univ"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "Intrathecal Injection of Mesenchymal Stem Cells in Central Nervous System Injury", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "life quality score", 
            "safety_issue": "No", 
            "time_frame": "1y"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01719640"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "1y"
        }, 
        "source": "Fuzhou General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fuzhou General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}